ArticleBone marrow transplantation2020

Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study.

Virginia Escamilla Gómez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.